Osimertinib resistance in non-small cell lung cancer: Pathways and potential solutions

Li et al. “Toward the next generation EGFR inhibitors: an overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancer.” Cell Communication and Signaling (2023)

Read the article: https://doi.org/10.1186/s12964-023-01082-8

Video produced by http://www.researchersquare.com/researchers/videos

• 类别